These findings align with the known roles of TP53 in regulating the cell cycle and DNA repair, suggesting that TP53 mutations may drive aberrant cellular processes that support tumorigenesis in NSCLC [44, 45]. Here, TP53 is linked to non-small cell lung carcinoma.